Top ▲
Ligand name | ID | Synonyms | |||||||
A | Back to top | ||||||||
852A |
![]() |
9025 | |||||||
A286982 |
![]() |
6592 | A 286982, A-286982 | ||||||
A438079 |
![]() |
4118 | A 438079, A-438079 | ||||||
AB680 |
![]() |
![]() |
10707 | AB-680 | |||||
AB928 |
![]() |
11154 | AB-928 | ||||||
abatacept |
![]() |
![]() |
6891 | BMS-188667, CTLA4-IgG4m, Orencia®, RG-1046, RG-2077 | |||||
abediterol |
![]() |
9326 | LAS-100977 | ||||||
AbGn-168H |
![]() |
10013 | AbGn-168, neihulizumab | ||||||
abrezekimab |
![]() |
9806 | CDP7766, UCB-4144, UCB4144, VR-942 | ||||||
abrilumab |
![]() |
11531 | AMG 181, AMG-181, MEDI-7183, MEDI7183 | ||||||
abrocitinib |
![]() |
![]() |
![]() |
9991 | Cibinqo®, compound 25 [PMID: 29298069], PF-04965842, PF04965842 | ||||
abscisic acid |
![]() |
10362 | (+/-)-(cis,trans)-abscisic acid, (+/-)-Abscisic acid, (RS)-Abscisic acid, ABA | ||||||
ABT-737 |
![]() |
![]() |
8320 | ABT 737, ABT737, compound 2 [PMID 17256834] | |||||
AC430 |
![]() |
9177 | AC-430 | ||||||
acalabrutinib |
![]() |
![]() |
8912 | ACP-196, Calquence®, Example 6 [US20140155385 A1] | |||||
Ac-SDKP |
![]() |
10060 | goralatide, seraspenide | ||||||
ACT-1014-6470 |
![]() |
12326 | example 172 [WO2019137927A1], Ic-58 | ||||||
ACT-389949 |
![]() |
9511 | |||||||
ACT-660602 |
![]() |
12207 | ACT660602, compound 9j [PMID: 35947786] | ||||||
ACT-777991 |
![]() |
12584 | ACT777991, compound 8a [PMID: 36883854] | ||||||
ACTH {Sp: Human} |
![]() |
![]() |
3633 | Acthar®, adrenocorticotropic hormone (1-39), corticotropin | |||||
acumapimod |
![]() |
9203 | BCT 197, BCT-197, BCT197, compound A [WO2013139809] | ||||||
adalimumab |
![]() |
![]() |
4860 | D2E7, Humira® | |||||
(-)-adrenaline |
![]() |
![]() |
![]() |
479 | adrenalin, Auvi-Q®, Epipen®, l-adrenaline, L-epinephrine, levoepinephrine | ||||
adrenomedullin {Sp: Human} |
![]() |
683 | AM | ||||||
adriforant |
![]() |
8985 | PF 3893787, PF-03893787, ZPL-389, ZPL-3893787, ZPL389, ZPL3893787 | ||||||
ADU-S100 |
![]() |
10192 | dithio-(Rp,Rp)-[cyclic[A(2',5')pA(3',5')p]], MIW815, ML RR-S2 CDA, S100 | ||||||
AF12198 |
![]() |
4861 | AF 12198, AF-12198 | ||||||
AFM13 |
![]() |
10067 | AFM 13, AFM-13 | ||||||
agatolimod |
![]() |
9843 | CpG 7909, CpG7909, PF 3512676, PF-3512676, ProMune, VaxImmune | ||||||
AH10-7 |
![]() |
9899 | |||||||
AH6809 |
![]() |
1896 | AH 6809, AH-6809 | ||||||
AL-78898A |
![]() |
9219 | 4(1MeW), POT-4 | ||||||
alcaftadine |
![]() |
![]() |
7587 | Lastacaft®, R-89674 | |||||
alefacept |
![]() |
![]() |
6787 | Amevive®, BG 9273, BG 9712, BG-9273, BG-9712, Lfa3Tip | |||||
alemtuzumab |
![]() |
![]() |
6770 | campath 1H, Campath®, campath-1H, Lemtrada® | |||||
alimemazine |
![]() |
![]() |
7237 | Nedeltran®, trimeprazine | |||||
3 alpha-aminocholestane |
![]() |
9564 | 3AC, 3 α-aminocholestane | ||||||
ALT-803 |
![]() |
9615 | IL-15 N72D:IL-15RαSu/Fc, IL-15SA, N-803 | ||||||
alvelestat |
![]() |
6476 | AZD 9668, AZD-9668, AZD9668, KB-105160 | ||||||
AM-461 |
![]() |
10170 | AM461, Compound 1 [WO2011085033] | ||||||
AM-6120 |
![]() |
10119 | AM6120, peptide 41 [PMID: 30346167] | ||||||
amcinonide |
![]() |
![]() |
7060 | CL-34699, Cyclocort® | |||||
amelubant |
![]() |
8463 | BIIL 284, BIIL-284 | ||||||
AMG319 |
![]() |
![]() |
8917 | AMG 319, AMG-319 | |||||
AMG820 |
![]() |
9106 | |||||||
aminopyridine 2 |
![]() |
10051 | |||||||
amiselimod |
![]() |
9319 | Example 1 [US20090137530], MT-1303, MT1303 | ||||||
amiselimod phosphate |
![]() |
9491 | amiselimod-P, MT-1303-P | ||||||
amlexanox |
![]() |
![]() |
![]() |
7113 | AA-673, Amlexanox®, Aphthasol®, CHX-3673 | ||||
amphiregulin {Sp: Human} |
![]() |
4864 | colorectal cell-derived growth factor (CRDGF) | ||||||
AMT-101 |
![]() |
11645 | |||||||
anakinra |
![]() |
![]() |
6972 | antril, Kineret® | |||||
anatumomab mafenatox |
![]() |
9947 | 5T4FabV13SEAD227A, ABR 214936, ABR-214936, ABR214936, pMB125, PNU 214936, PNU-214936, PNU214936, TTS-CD2 | ||||||
ancriviroc |
![]() |
804 | SCH 351125, SCH-351125, SCH-C | ||||||
andecaliximab |
![]() |
9510 | GS-5745, GS5745 | ||||||
andrographolide |
![]() |
9675 | |||||||
anifrolumab |
![]() |
![]() |
8258 | anifrolumab-fnia, MDX-1333, MEDI-546, Saphnelo® | |||||
apafant |
![]() |
1860 | WEB 2086 BS, WEB-2086 | ||||||
apilimod |
![]() |
9859 | LAM-002A (apilimod dimesylate), LAM002A, STA 5326, STA-5326, STA5326 | ||||||
apratastat |
![]() |
6482 | compound 5h [PMID: 16426848], TMI-05, TMI005 | ||||||
apremilast |
![]() |
![]() |
![]() |
7372 | CC-10004, Otezla® | ||||
APRIL {Sp: Human} |
![]() |
5068 | A proliferation-inducing ligand, TALL2, TNF- and APOL-related leukocyte expressed ligand 2, TNF-related death ligand 1, TRDL-1, ZTNF2 | ||||||
arformoterol |
![]() |
![]() |
![]() |
7479 | Brovana®, YM-08316 | ||||
ARN19702 |
![]() |
![]() |
10120 | ARN-19702, compound 8 [PMID: 27404798] | |||||
ARN726 |
![]() |
9178 | ARN-726, compound 6 [PMID: 25874594] | ||||||
(R)-ARN2508 |
![]() |
9000 | compound (-)-10r [PMID: 26774927], example 19 [WO2014023643] | ||||||
(S)-ARN2508 |
![]() |
![]() |
8999 | compound (+)-10r [PMID: 26774927], example 20 [WO2014023643] | |||||
arpromidine |
![]() |
1221 | ARP | ||||||
ARRY-371797 |
![]() |
11095 | ARRY-797, ARRY371797, ARRY797, compound 7 [PMID: 19950901] | ||||||
ARRY-382 |
![]() |
9108 | ARRY 382, ARRY382, c-Fms-IN-12, PF-07265804, PF07265804 | ||||||
ARRY-502 |
![]() |
10179 | ARRY502, example 237, enantiomer 1 [WO2009158426A1] | ||||||
AS101 |
![]() |
437 | ammonium tri-chloro(dioxoethylene-O,O'-)tellurate, AS 101, AS-101 | ||||||
AS-252424 |
![]() |
10578 | AS252424, compound 26 [PMID: 16789742] | ||||||
asapiprant |
![]() |
11951 | BGE-175, BGE175, example II-74 [US8153793B2], S-555739 | ||||||
asimadoline |
![]() |
9279 | EMD 61 753, EMD 61753, EMD-61753 | ||||||
asivatrep |
![]() |
9621 | Example 230 [US7858621], PAC-14028 | ||||||
ASP4058 |
![]() |
9569 | ASP-4058 | ||||||
aspirin |
![]() |
![]() |
![]() |
4139 | Acetophen®, acetylsalicylic acid, Aspirin® | ||||
aspirin-triggered resolvin D1 |
![]() |
6239 | AT-Resolvin D1, AT-RvD1 | ||||||
AT38 |
![]() |
9020 | [3-(aminocarbonyl)furoxan-4-yl]methyl salicylate | ||||||
atacicept |
![]() |
9517 | TACI-Fc, TACI-Ig | ||||||
atezolizumab |
![]() |
![]() |
7990 | MPDL3280A, Tecentriq® | |||||
ATI-50001 |
![]() |
12317 | ATI-501, ATI50001, ATI501, example 103 [WO2007070872A1] | ||||||
atibuclimab |
![]() |
11326 | IC14 | ||||||
atracurium |
![]() |
![]() |
9537 | atracurium besilate, atracurium dibesylate, BW 33A, Tracrium® | |||||
auranofin |
![]() |
![]() |
6306 | Ridaura®, SK&F-39162, SK-39162 | |||||
avacopan |
![]() |
![]() |
![]() |
9450 | CCX-168, CCX168, Tavneos® | ||||
avadomide |
![]() |
10522 | CC-122, CC122, Compound A [WO2014039960A1] | ||||||
avapritinib |
![]() |
![]() |
10368 | Ayvakit®, Ayvakyt®, BLU-285, BLU285 | |||||
avdoralimab |
![]() |
11345 | anti-hC5aR-32F3A6 GL, IPH-5401, NN-8210, NNC-0215-0384 | ||||||
AVE 0991 |
![]() |
5579 | AVE-0991, AVE0991 | ||||||
avelumab |
![]() |
![]() |
8735 | Bavencio®, MSB-0010718C, MSB0010718C | |||||
AX-024 |
![]() |
11253 | AX-24, AX024 | ||||||
AZ13102909 |
![]() |
9577 | AZ909 | ||||||
AZ2 |
![]() |
![]() |
10233 | ||||||
AZ3451 |
![]() |
![]() |
9560 | ||||||
AZ7188 |
![]() |
9586 | |||||||
AZ8838 |
![]() |
![]() |
9585 | ||||||
azacitidine |
![]() |
![]() |
![]() |
6796 | 5-AZAC, 5-azacytidine, ladakamycin, Onureg®, Onureg® (CC-486; oral azacitidine), U-18496, Vidaza® | ||||
azapro-3 |
![]() |
9221 | |||||||
azatadine |
![]() |
![]() |
7119 | Optimine®, SCH-10649 | |||||
azathioprine |
![]() |
![]() |
7120 | Azasan®, BW-57-322, Imuran®, Jayempi® | |||||
AZD0284 |
![]() |
![]() |
11711 | AZD-0284, compound 20 [PMID: 34464130] | |||||
AZD1236 |
![]() |
7844 | AZD 1236, AZD-1236 | ||||||
AZD1678 |
![]() |
9679 | AZD-1678, compound 49 [PMID: 28947948] | ||||||
AZD1981 |
![]() |
7680 | AZD 1981, AZD-1981 | ||||||
AZD2098 |
![]() |
9678 | AZD-2098, compound 47 [PMID: 28947948] | ||||||
AZD2423 |
![]() |
7825 | AZD 2423, AZD-2423 | ||||||
AZD3458 |
![]() |
9997 | AZD-3458, compound 15 [PMID: 29852070] | ||||||
AZD3965 |
![]() |
10605 | AZD-3965 | ||||||
AZD4604 |
![]() |
11716 | AZD-4604, example 35 [WO2018134213A1], Jak1-IN-7 | ||||||
AZD5069 |
![]() |
8948 | AZD-5069 | ||||||
AZD5672 |
![]() |
7686 | AZD 5672, AZD-5672 | ||||||
AZD5718 |
![]() |
10352 | compound 12 [PMID: 30869888] | ||||||
AZD6605 |
![]() |
7823 | AZ 11920155, AZ-11920155, AZ11920155, AZD 6605, AZD-6605 | ||||||
AZD6703 |
![]() |
![]() |
7687 | AZ 12012199, AZ-12012199, AZ12012199, AZD 6703, AZD-6703 | |||||
AZD7624 |
![]() |
11714 | AZD-7624, Example 259 [WO2009001132] | ||||||
AZD8154 |
![]() |
![]() |
11204 | AZD-8154, Example 1 [WO2018055040A1] | |||||
AZD8848 |
![]() |
9256 | DSP-3025 | ||||||
AZD9056 |
![]() |
7826 | AZD 9056, AZD-9056 | ||||||
AZD9567 |
![]() |
![]() |
9812 | AZD 9567, AZD-9567, compound 15 [PMID: 29424542], example 1 [WO2016046260A1] | |||||
AZD9898 |
![]() |
10479 | AZD-9898, example 62 [WO2016177845A1] | ||||||
azelaic acid |
![]() |
![]() |
![]() |
7484 | Azelex®, Finacea®, ZK-62498 | ||||
azithromycin |
![]() |
![]() |
![]() |
![]() |
6510 | ||||
AZ11657312 (salt free) |
![]() |
7722 | |||||||
B | Back to top | ||||||||
bafetinib |
![]() |
![]() |
7906 | INNO-406, Lyn-IN-1, NS-187 | |||||
BAFF {Sp: Human} |
![]() |
5069 | B cell-activating factor, CD257 antigen, dendritic cell-derived TNF-like molecule | ||||||
balamapimod |
![]() |
9925 | MKI-833, MKI833 | ||||||
bardoxolone |
![]() |
2717 | CDDO, RTA-401 | ||||||
baricitinib |
![]() |
![]() |
![]() |
7792 | INCB-028050, INCB028050, LY-3009104, LY3009104, Olumiant® | ||||
basiliximab |
![]() |
![]() |
6879 | CHI-621, L04AC02, SDZ-CHI-621, Simulect® | |||||
BAY 11-7082 |
![]() |
5934 | (E)-3-tosylacrylonitrile, BAY-117082, BAY117082 | ||||||
BAY-985 |
![]() |
10597 | BAY985, compound 34 [PMID: 31859507] | ||||||
BAYu9773 |
![]() |
3381 | BAY u9773, BAY-u 9773 | ||||||
beclometasone |
![]() |
![]() |
![]() |
7059 | beclomethasone, SCH-18020W | ||||
beclometasone dipropionate |
![]() |
![]() |
5894 | beclomethasone dipropionate, Beconase®, Qnasl®, Vancenase® | |||||
begelomab |
![]() |
8691 | Begendina&rg; (proprietary name), BT 5/9, SAND 26 | ||||||
belantamab mafodotin |
![]() |
![]() |
11117 | belamaf, belantamab mafodotin-blmf, Blenrep®, GSK-2857916, GSK2857916 | |||||
belatacept |
![]() |
![]() |
6892 | BMS-224818, LEA29Y, Nulojix® | |||||
belimumab |
![]() |
![]() |
6887 | Benlysta®, hBlySmAb-1.1, LimphoStat-B, lymphostat-B | |||||
belnacasan |
![]() |
9035 | HMR3480, VX-765 | ||||||
belumosudil |
![]() |
![]() |
![]() |
9558 | KD-025, KD025, Rezurock®, SLx 2119, SLx2119 | ||||
bempegaldesleukin |
![]() |
10659 | NKTR-214, NKTR214 | ||||||
benralizumab |
![]() |
![]() |
7674 | BIW-8405, Fasenra®, KHK4563, MEDI-563 | |||||
bentamapimod |
![]() |
9926 | AS-602801, AS602801, PGL-5001, PGL5001 | ||||||
benzodrocortisone |
![]() |
9731 | compound 1 [WO2013071010], hydrocortisone 17-benzoate | ||||||
3beta-Hydroxy-20(29)-lupene |
![]() |
9028 | Fagarasterol, Lupeol | ||||||
betamethasone |
![]() |
![]() |
7061 | SCH-4831 | |||||
BI-1015550 |
![]() |
12518 | BI 1015550, BI1015550 | ||||||
BI-1935 |
![]() |
9717 | BI 1935, example 3 [WO2007067836] | ||||||
BI-1950 |
![]() |
9719 | |||||||
BI-2545 |
![]() |
![]() |
9791 | BI2545, compound 19 [PMID: 29259743] | |||||
BI605906 |
![]() |
9357 | 3-Amino-4-(1,1-difluoro- propyl)-6-(4-methanesulfonyl- piperidin-1-yl)-thieno[2,3- b]pyridine-2-carboxylic acid amide, compound 115 [US20070293533] | ||||||
BI 653048 |
![]() |
9715 | (R)-39, BI 653048 BS H3PO4, BI-653048, BI653048 | ||||||
BI 665915 |
![]() |
9716 | BI-665915, compound 69 [PMID: 25671290] | ||||||
BI-6901 |
![]() |
9714 | BI 6901, BI 6901, BI6901, eut-22 | ||||||
bifikafusp alfa |
![]() |
9756 | Darleukin, L19-IL2, L19IL2 | ||||||
bihelical apoA-I mimetic peptide 5A |
![]() |
9183 | 5A peptide | ||||||
BIIB068 |
![]() |
![]() |
11178 | BIIB-068, compound 1 [PMID: 32696648] | |||||
bimekizumab |
![]() |
![]() |
9411 | Bimzelx®, CA028_0496, CDP4940, gL7gH9, UCB-4940, UCB4940, Zu-G1 | |||||
bimosiamose |
![]() |
9049 | compound 15e [PMID: 9544210], TBC 1269, TBC-1269, TBC1269 | ||||||
bindarit |
![]() |
11124 | AF-2838, AF2838 | ||||||
BIRT 377 |
![]() |
9720 | BIRT-377 | ||||||
blinatumomab |
![]() |
![]() |
7384 | Blincyto®, bscCD19xCD3, MEDI-538, MT-103, MT103 | |||||
blisibimod |
![]() |
9518 | A-623, AGP3 peptibody, AMG 623, Fc-Agp-3 | ||||||
BML-281 |
![]() |
9664 | compound 3 [PMID: 18642892] | ||||||
BMS-1001 |
![]() |
10191 | BMS1001, Example 1001 [WO2015160641A2] | ||||||
BMS-1166 |
![]() |
9608 | compound 2c [PMID: 28613862], Example 1166 [WO2015160641A2] | ||||||
BMS-202 |
![]() |
![]() |
9607 | compound 1c [PMID: 28613862], PD1-PDL1 inhibitor 2 | |||||
BMS-345541 |
![]() |
5669 | BMS 345541, BMS345541 | ||||||
BMS-509744 |
![]() |
9994 | BMS 509744, BMS509744, compound 3 [PMID:16682193] | ||||||
BMS-561392 |
![]() |
6509 | BMS 561392, BMS561392, DPC-333 | ||||||
BMS-582949 |
![]() |
![]() |
7838 | BMS 582949, BMS582949, PS 540446, PS-540446, PS540446 | |||||
BMS-681 |
![]() |
![]() |
9430 | compound 13d [PMID: 25893046] | |||||
BMS-817399 |
![]() |
![]() |
9497 | compound 29 [PMID: 25101488] | |||||
BMS-986142 |
![]() |
![]() |
9857 | BMS986142, compound 14f [PMID: 27583770] | |||||
BMS-986166 |
![]() |
11493 | BMS986166, compound 14a [PMID: 30785748] | ||||||
BMS-986235 |
![]() |
11024 | BMS986235, compound 13c [PMID: 32407089], LAR-1219, LAR1219 | ||||||
BMS-986260 |
![]() |
![]() |
10662 | BMS986260, compound 10 [Velaparthi et al., 2020], Example 32' [WO2016140884A1] | |||||
BMS-986104 derivative 12 |
![]() |
11494 | compound 12 [PMID: 33492963] | ||||||
BMS-986104 derivative 24 |
![]() |
11495 | compound 24 [PMID: 33492963] | ||||||
bortezomib |
![]() |
![]() |
![]() |
![]() |
6391 | peptide boronate, PS-341, Velcade® | |||
bosutinib |
![]() |
![]() |
![]() |
5710 | Bosulif®, SK 606, SK-606, SKI 606 | ||||
branebrutinib |
![]() |
9869 | BMS-986195, BMS986195, Example 223 [US20160115126A1] | ||||||
brazikumab |
![]() |
9293 | AMG 139, AMG-139, MEDI2070 | ||||||
brensocatib |
![]() |
9412 | AZD7986, compound 30, INS 1007, INS1007 | ||||||
brentuximab vedotin |
![]() |
![]() |
6772 | Adcetris®, anti-CD30 ADC SGN-35, SGN 35 | |||||
brepocitinib |
![]() |
![]() |
10459 | compound 23 [PMID: 30113844], PF-06700841, PF06700841 | |||||
briakinumab |
![]() |
9213 | ABT-874, J-695, J695, Ozespa | ||||||
brimapitide |
![]() |
9101 | AM-111, D-JNKI-1, XG-102 | ||||||
brimonidine |
![]() |
![]() |
![]() |
520 | Alphagan®, Lumify®, Mirvaso®, UK14,304, UK14304 | ||||
BRL-15572 |
![]() |
10 | BRL 15572, BRL-15,572, BRL15572 | ||||||
brodalumab |
![]() |
![]() |
7540 | AMG-827, AMG827, Kyntheum®, Lumicef®, Siliq® | |||||
bromfenac |
![]() |
![]() |
![]() |
7131 | AHR-10282B, Bromday®, Prolensa®, Xibrom® | ||||
BsAb (CD89-CD20) |
![]() |
9833 | |||||||
BT-11 |
![]() |
10363 | analogue 7 [PMID: 27933891], BT11, Example 1 [US9556146B2] | ||||||
BT7480 |
![]() |
12060 | BCY11863, BT-7480 | ||||||
BTP2 |
![]() |
2438 | YM-58483 | ||||||
budesonide |
![]() |
![]() |
7434 | Entocort®, Eohilia® (budesonide oral suspension), Jorveza®, Pulmicort®, S-1320, Uceris® | |||||
butyric acid |
![]() |
![]() |
1059 | butanoic acid, butyrate, C4 | |||||
BX 471 |
![]() |
767 | BX-471, BX-741 | ||||||
BX-795 |
![]() |
![]() |
8006 | BX 795, BX795 | |||||
C | Back to top | ||||||||
C108297 |
![]() |
9180 | Compound 52 [PMID:18226897] | ||||||
C1-27 |
![]() |
![]() |
10719 | GSTO1-IN-1 | |||||
C391 |
![]() |
9570 | compound 5 [PMID: 27994760] | ||||||
C646 |
![]() |
7004 | |||||||
C5a {Sp: Human} |
![]() |
573 | C5a anaphylatoxin, complement component C5a, human complement protein | ||||||
cabiralizumab |
![]() |
9107 | BMS-986227, FPA-008, FPA008 | ||||||
camrelizumab |
![]() |
![]() |
9758 | INCSHR1210, SHR-1210 | |||||
canakinumab |
![]() |
![]() |
6773 | ACZ 885, ACZ885, Ilaris® | |||||
canertinib |
![]() |
5675 | CI 1033, CI-1033, PD 183805 dihydrochloride | ||||||
carotegrast |
![]() |
10511 | HCA2969 | ||||||
carotegrast methyl |
![]() |
![]() |
10510 | AJM-300, AJM300, Carogra® | |||||
carprofen |
![]() |
![]() |
7141 | Ro-205720000 | |||||
CBS-3595 |
![]() |
9610 | |||||||
CC-885 |
![]() |
9224 | |||||||
CC-99677 |
![]() |
12167 | CC99677 | ||||||
CCL1 {Sp: Human} |
![]() |
812 | I309, TCA-3 | ||||||
CCL11 {Sp: Human} |
![]() |
769 | eotaxin | ||||||
CCL13 {Sp: Human} |
![]() |
770 | monocyte chemotactic protein-4 | ||||||
CCL14 {Sp: Human} |
![]() |
753 | CCL14a, CKβ1, haemofiltrate CC chemokine 1 (HCC-1), HCC-1(1-74) | ||||||
CCL15 {Sp: Human} |
![]() |
754 | Lkn-1 [Leukotactin-1], macrophage inflammatory protein-1δ, MIP-1δ | ||||||
CCL16 {Sp: Human} |
![]() |
1272 | |||||||
CCL17 {Sp: Human} |
![]() |
797 | TARC, thymus- and activation-regulated chemokine | ||||||
CCL18 {Sp: Human} |
![]() |
4382 | macrophage inflammatory protein 4, small-inducible cytokine A18 | ||||||
CCL19 {Sp: Human} |
![]() |
810 | β-chemokine exodus-3, ck β-11, ckβ11, MIP-3β | ||||||
CCL2 {Sp: Human} |
![]() |
771 | |||||||
CCL20 {Sp: Human} |
![]() |
808 | LARC, liver and activation-regulated chemokine, macrophage inflammatory protein-3α, MIP-3α | ||||||
CCL21 {Sp: Human} |
![]() |
811 | ckβ9, TCA-4 | ||||||
CCL22 {Sp: Human} |
![]() |
798 | dc/β-ck, macrophage-derived chemokine, STCP1 | ||||||
CCL23 {Sp: Human} |
![]() |
755 | ckβ8-1, myeloid progenitor inhibitor factor-1 | ||||||
CCL24 {Sp: Human} |
![]() |
775 | eotaxin-2 | ||||||
CCL25 {Sp: Human} |
![]() |
817 | |||||||
CCL26 {Sp: Human} |
![]() |
776 | MIP-4α, PTEC | ||||||
CCL27 {Sp: Human} |
![]() |
3646 | |||||||
CCL28 {Sp: Human} |
![]() |
3649 | |||||||
CCL3 {Sp: Human} |
![]() |
756 | macrophage inflammatory protein-1α, MIP-1α | ||||||
CCL4 {Sp: Human} |
![]() |
757 | HC21, macrophage inflammatory protein-1β, MIP-1β | ||||||
CCL5 {Sp: Human} |
![]() |
758 | eosinophil chemotactic cytokine [EoCP], regulated upon activation normal T cell expressed and secreted (RANTES) | ||||||
CCL7 {Sp: Human} |
![]() |
759 | |||||||
CCL8 {Sp: Human} |
![]() |
772 | monocyte chemotactic protein-2 | ||||||
CCL1 {Sp: Mouse} |
![]() |
4404 | |||||||
CCL11 {Sp: Mouse} |
![]() |
787 | murine eotaxin | ||||||
CCL12 {Sp: Mouse} |
![]() |
4435 | |||||||
CCL19 {Sp: Mouse} |
![]() |
4417 | |||||||
CCL2 {Sp: Mouse} |
![]() |
4406 | |||||||
CCL20 {Sp: Mouse} |
![]() |